Raloxifene is a selective estrogen receptor modulator used to prevent and treat osteoporosis in postmenopausal women.
Raloxifene belongs to a class of medicines called selective estrogen receptor modulators (SERMs). It mimics estrogen in some parts of the body while blocking its action in others. In Hong Kong, raloxifene is primarily used to help maintain bone strength and reduce the risk of fractures.
The most common product that contains raloxifene is the brand-name tablet Evista. It is also available as a generic tablet simply labelled “Raloxifene.” Both forms come in 60 mg tablets that are taken by mouth. These tablets are approved for use in Hong Kong under the Medicines and Poisons Ordinance and are supplied by pharmacies with a prescription from a qualified practitioner.
These uses are based on the ingredient’s action in the body rather than on any specific product formulation.
Raloxifene attaches to estrogen receptors in bone and mimics the hormone’s protective effects, helping bone cells rebuild and stay strong. In breast and uterine tissue, it blocks estrogen, preventing the hormone from stimulating growth there. Because it works selectively, the drug can provide bone benefits without the full range of estrogen-related side effects. Effects on bone can be noticed within a few weeks, but the full benefit for fracture risk may take several months.
These reactions are usually temporary and resolve without medical intervention.
If any of these occur, seek emergency medical help promptly.
Raloxifene can interact with other medicines that affect blood clotting, such as anticoagulants, and with hormone therapies. Alcohol consumption may increase the risk of certain side effects, so moderate intake is advisable. Certain foods do not significantly alter its effect, but it is best to follow the specific guidance on each product label. For a complete list of possible interactions, refer to the individual medication’s information page.
Store raloxifene tablets at room temperature, away from excess moisture and direct sunlight. The medication is usually prescribed for long-term use in chronic bone-health management, but the exact duration depends on the individual product and patient’s condition. Always read the accompanying patient information leaflet and follow the directions provided for each specific brand or generic version. For detailed usage, dosing, administration, refer to your specific medication's information.
Selective estrogen receptor modulator (SERM): A drug that can both activate and block estrogen receptors depending on the tissue type.
Post-menopausal: Refers to the stage after a woman has not had a menstrual period for twelve consecutive months.
Bone mineral density (BMD): A measurement of the amount of mineral (such as calcium) in a specific volume of bone, used to assess bone strength.
Thromboembolism: The formation of a blood clot that can travel through the bloodstream and block a vessel.
This article offers general educational information about raloxifene as an active substance used in various medicines. Its purpose is to help patients better understand the ingredient and the conditions it is used to treat. It is not a substitute for professional medical advice or for the specific instructions provided with individual products. Medicines containing raloxifene may differ in formulation, strength, and directions for use. Always consult the labeling of your particular medication and follow your healthcare provider’s guidance for complete information on proper use, dosage, and safety.
